State of Alaska Department of Revenue Sells 3,655 Shares of CME Group Inc. (NASDAQ:CME)

State of Alaska Department of Revenue cut its position in CME Group Inc. (NASDAQ:CME) by 6.7% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 50,527 shares of the financial services provider’s stock after selling 3,655 shares during the period. State of Alaska Department of Revenue’s holdings in CME Group were worth $10,877,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CME. B. Riley Wealth Advisors Inc. raised its holdings in shares of CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after purchasing an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC raised its stake in CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after buying an additional 48 shares during the last quarter. Lantz Financial LLC lifted its holdings in shares of CME Group by 1.1% during the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after buying an additional 49 shares during the period. Transcend Capital Advisors LLC boosted its stake in shares of CME Group by 1.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after buying an additional 50 shares during the last quarter. Finally, Greystone Financial Group LLC grew its holdings in shares of CME Group by 1.6% in the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after acquiring an additional 52 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 54,290 shares of company stock worth $11,393,700. 0.30% of the stock is currently owned by insiders.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $196.06 on Thursday. The firm has a fifty day simple moving average of $204.50 and a two-hundred day simple moving average of $208.41. CME Group Inc. has a 52 week low of $180.11 and a 52 week high of $223.80. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $70.60 billion, a P/E ratio of 22.30, a PEG ratio of 5.20 and a beta of 0.52.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter last year, the business posted $2.42 earnings per share. The firm’s revenue was up 3.2% on a year-over-year basis. On average, analysts expect that CME Group Inc. will post 9.75 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were paid a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.35%. CME Group’s payout ratio is 52.33%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CME. Argus upped their price target on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Morgan Stanley raised their target price on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Barclays upped their price target on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 25th. Rosenblatt Securities restated a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Finally, Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $226.00 target price on shares of CME Group in a report on Wednesday. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $215.90.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.